Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy

References

• Graham R. M., Bishopric N. H., Webster K. A. Gene and cell therapy for heart disease. IUBMB Life 2002; 54: 59–66
   PubMedGoogle Scholar
• Hamano K., Li T. S., Kobayashi T., Tanaka N., Kobayashi S., Matsuzaki M., et al. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method. Surgery 2001; 130: 44–54
   PubMed Web of Science ®Google Scholar
• Siepe M., Heilmann C., von Samson P., Menasche P., Beyersdorf F. Stem cell research and cell transplantation for myocardial regeneration. Eur J Cardiothorac Surg 2005
   PubMedGoogle Scholar
• Yongzhong W., Johnsen H. E., Jorgensen E., Kastrup J. The clinical impact of vascular growth factors and endothelial progenitor cells in the acute coronary syndrome. Scand Cardiovasc J 2003; 37: 18–22
   PubMed Web of Science ®Google Scholar
• Lee M. S., Lill M., Makkar R. R. Stem cell transplantation in myocardial infarction. Rev Cardiovasc Med 2004; 5: 82–98
   Google Scholar
• Minguell J. J., Erices A., Conget P. Mesenchymal stromal cells. Exp Biol Med (Maywood) 2001; 226: 507–20
   PubMed Web of Science ®Google Scholar
• Fuchs S., Baffour R., Zhou Y. F., Shou M., Pierre A., Tio F. O., et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001; 37: 1726–32
   PubMed Web of Science ®Google Scholar
• Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001; 104: 1046–52
   PubMed Web of Science ®Google Scholar
• Kocher A. A., Schuster M. D., Szabolcs M. J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone‐marrow‐derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430–6
   PubMed Web of Science ®Google Scholar
• Liu Y., Guo J., Zhang P., Zhang S., Chen P., Ma K., et al. Bone marrow mononuclear cell transplantation into heart elevates the expression of angiogenic factors. Microvasc Res 2004; 68: 156–60
   PubMedGoogle Scholar
• Shyu K. G., Wang B. W., Hung H. F., Chang C. C., Shih D. T. Mesenchymal stromal cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction. J Biomed Sci 2006; 13: 47–58
   PubMed Web of Science ®Google Scholar
• Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE‐AMI). Circulation 2002; 106: 3009–17
   PubMed Web of Science ®Google Scholar
• Fernandez‐Aviles F., San Roman J. A., Garcia‐Frade J., Fernandez M. E., Penarrubia M. J., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004; 95: 742–8
   PubMed Web of Science ®Google Scholar
• Galinanes M., Loubani M., Davies J., Chin D., Pasi J., Bell P. R. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant 2004; 13: 7–13
   PubMed Web of Science ®Google Scholar
• Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Intracoronary bone marrow‐derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210–21
   PubMed Web of Science ®Google Scholar
• Strauer B. E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R. V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913–18
   PubMed Web of Science ®Google Scholar
• Wollert K. C., Meyer G. P., Lotz J., Ringes‐Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone‐marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141–8
   PubMed Web of Science ®Google Scholar
• Beeres S. L., Bax J. J., Kaandorp T. A., Zeppenfeld K., Lamb H. J., bbets‐Schneider P., et al. Usefulness of intramyocardial injection of autologous bone marrow‐derived mononuclear cells in patients with severe angina pectoris and stress‐induced myocardial ischemia. Am J Cardiol 2006; 97: 1326–31
   PubMed Web of Science ®Google Scholar
• Fuchs S., Satler L. F., Kornowski R., Okubagzi P., Weisz G., Baffour R., et al. Catheter‐based autologous bone marrow myocardial injection in no‐option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 2003; 41: 1721–4
   PubMed Web of Science ®Google Scholar
• Kuethe F., Richartz B. M., Kasper C., Sayer H. G., Hoeffken K., Werner G. S., et al. Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans. Int J Cardiol 2005; 100: 485–91
   PubMed Web of Science ®Google Scholar
• Perin E. C., Dohmann H. F., Borojevic R., Silva S. A., Sousa A. L., Mesquita C. T., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107: 2294–302
   PubMed Web of Science ®Google Scholar
• Stamm C., Westphal B., Kleine H. D., Petzsch M., Kittner C., Klinge H., et al. Autologous bone‐marrow stem‐cell transplantation for myocardial regeneration. Lancet 2003; 361: 45–6
   PubMed Web of Science ®Google Scholar
• Tse H. F., Kwong Y. L., Chan J. K., Lo G., Ho C. L., Lau C. P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361: 47–9
   PubMed Web of Science ®Google Scholar
• Ince H., Nienaber C. A. Future investigations in stem cell activation with granulocyte‐colony‐stimulating factor after myocardial infarction. Nat Clin Pract Cardiovasc Med 2007; 4 Suppl 1: S119–22
   Google Scholar
• Jorgensen E., Ripa R. S., Helqvist S., Wang Y., Johnsen H. E., Grande P., et al. In‐stent neo‐intimal hyperplasia after stem cell mobilization by granulocyte‐colony stimulating factor. Preliminary intracoronary ultrasound results from a double‐blind randomized placebo‐controlled study of patients treated with percutaneous coronary intervention for ST‐elevation myocardial infarction (STEMMI Trial). Int J Cardiol 2006; 111: 174–7
   PubMed Web of Science ®Google Scholar
• Ripa R. S., Jorgensen E., Wang Y., Thune J. J., Nilsson J. C., Sondergaard L., et al. Stem cell mobilization induced by subcutaneous granulocyte‐colony stimulating factor to improve cardiac regeneration after acute ST‐elevation myocardial infarction: result of the double‐blind, randomized, placebo‐controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006; 113: 1983–92
   PubMed Web of Science ®Google Scholar
• Wang Y., Tagil K., Ripa R. S., Nilsson J. C., Carstensen S., Jorgensen E., et al. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int J Cardiol 2005; 100: 477–83
   PubMed Web of Science ®Google Scholar
• Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., et al. Autologous bone marrow‐derived stem‐cell transfer in patients with ST‐segment elevation myocardial infarction: double‐blind, randomised controlled trial. Lancet 2006; 367: 113–21
   PubMed Web of Science ®Google Scholar
• Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199–209
   PubMed Web of Science ®Google Scholar
• Oswald J., Boxberger S., Jorgensen B., Feldmann S., Ehninger G., Bornhauser M., et al. Mesenchymal stromal cells can be differentiated into endothelial cells in vitro. Stem Cells 2004; 22: 377–84
   PubMed Web of Science ®Google Scholar
• Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., et al. Multilineage potential of adult human mesenchymal stromal cells. Science 1999; 284: 143–7
   PubMed Web of Science ®Google Scholar
• Silva G. V., Litovsky S., Assad J. A., Sousa A. L., Martin B. J., Vela D., et al. Mesenchymal stromal cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005; 111: 150–6
   PubMed Web of Science ®Google Scholar
• Iwase T., Nagaya N., Fujii T., Itoh T., Murakami S., Matsumoto T., et al. Comparison of angiogenic potency between mesenchymal stromal cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 2005; 66: 543–51
   PubMed Web of Science ®Google Scholar
• Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P. H., Verfaillie C. M. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109: 337–46
   PubMed Web of Science ®Google Scholar
• Kanayasu‐Toyoda T., Yamaguchi T., Oshizawa T., Hayakawa T. CD31 (PECAM‐1)‐bright cells derived from AC133‐positive cells in human peripheral blood as endothelial‐precursor cells. J Cell Physiol 2003; 195: 119–29
   PubMed Web of Science ®Google Scholar
• Kawamoto A., Gwon H. C., Iwaguro H., Yamaguchi J. I., Uchida S., Masuda H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634–7
   PubMed Web of Science ®Google Scholar
• Bindslev L., Haack‐Sorensen M., Bisgaard K., Kragh L., Mortensen S., Hesse B., et al. Labelling of human mesenchymal stromal cells with indium‐111 for SPECT imaging: effect on cell proliferation and differentiation. Eur J Nucl Med Mol Imaging 2006; 33: 1171–7
   PubMed Web of Science ®Google Scholar
• Haack‐Sorensen M., Bindslev L., Mortensen S., Friis T., Kastrup J. The influence of freezing and storage on characteristics and functions of human mesenchymal stromal cells isolated for clinical use. Cytotherapy 2007. In press
   Google Scholar
• Rickard D. J., Kassem M., Hefferan T. E., Sarkar G., Spelsberg T. C., Riggs B. L. Isolation and characterization of osteoblast precursor cells from human bone marrow 1. J Bone Miner Res 1996; 11: 312–24
   PubMedGoogle Scholar
• Reyes M., Verfaillie C. M. Characterization of multipotent adult progenitor cells: a subpopulation of mesenchymal stromal cells. Ann NY Acad Sci 2001; 938: 231–3
   PubMed Web of Science ®Google Scholar
• Prockop D. J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71–4
   PubMed Web of Science ®Google Scholar
• Sekiya I., Larson B. L., Smith J. R., Pochampally R., Cui J. G., Prockop D. J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002; 20: 530–41
   PubMed Web of Science ®Google Scholar
• Gregory C. A., Prockop D. J., Spees J. L. Non‐hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp Cell Res 2005; 306: 330–5
   PubMed Web of Science ®Google Scholar
• Herzog E. L., Chai L., Krause D. S. Plasticity of marrow‐derived stem cells. Blood 2003; 102: 3483–93
   PubMed Web of Science ®Google Scholar
• Kassem M., Kristiansen M., Abdallah B. M. Mesenchymal stromal cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 2004; 95: 209–14
   PubMed Web of Science ®Google Scholar
• Kim D. H., Yoo K. H., Choi K. S., Choi J., Choi S. Y., Yang S. E., et al. Gene expression profile of cytokine and growth factor during differentiation of bone marrow‐derived mesenchymal stromal cells. Cytokine 2005; 31: 119–26
   PubMed Web of Science ®Google Scholar
• Mizuno N., Shiba H., Ozeki Y., Mouri Y., Niitani M., Inui T., et al. Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stromal cell cultures. Cell Biol Int 2006; 30: 521–4
   PubMed Web of Science ®Google Scholar
• Stute N., Holtz K., Bubenheim M., Lange C., Blake F., Zander A. R. Autologous serum for isolation and expansion of human mesenchymal stromal cells for clinical use. Exp Hematol 2004; 32: 1212–25
   PubMed Web of Science ®Google Scholar
• Gronthos S., Simmons P. J. The growth factor requirements of STRO‐1‐positive human bone marrow stromal precursors under serum‐deprived conditions in vitro. Blood 1995; 85: 929–40
   PubMed Web of Science ®Google Scholar
• Meuleman N., Tondreau T., Delforge A., Dejeneffe M., Massy M., Libertalis M., et al. Human marrow mesenchymal stromal cell culture: serum‐free medium allows better expansion than classical alpha‐MEM medium. Eur J Haematol 2006; 76: 309–16
   PubMed Web of Science ®Google Scholar
• Muller I., Kordowich S., Holzwarth C., Spano C., Isensee G., Staiber A., et al. Animal serum‐free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 2006; 8: 437–44
   PubMed Web of Science ®Google Scholar
• Li T. S., Hamano K., Nishida M., Hayashi M., Ito H., Mikamo A., et al. CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol 2003; 285: H931–7
   PubMed Web of Science ®Google Scholar
• Matsumura G., Miyagawa‐Tomita S., Shin'oka T., Ikada Y., Kurosawa H. First evidence that bone marrow cells contribute to the construction of tissue‐engineered vascular autografts in vivo. Circulation 2003; 108: 1729–34
   PubMed Web of Science ®Google Scholar
• Min J. Y., Sullivan M. F., Yang Y., Zhang J. P., Converso K. L., Morgan J. P., et al. Significant improvement of heart function by cotransplantation of human mesenchymal stromal cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg 2002; 74: 1568–75
   PubMed Web of Science ®Google Scholar
• Wang J. S., Shum‐Tim D., Chedrawy E., Chiu R. C. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 2001; 122: 699–705
   PubMed Web of Science ®Google Scholar
• Katritsis D. G., Sotiropoulou P. A., Karvouni E., Karabinos I., Korovesis S., Perez S. A., et al. Transcoronary transplantation of autologous mesenchymal stromal cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 2005; 65: 321–9
   PubMed Web of Science ®Google Scholar
• Katritsis D. G., Sotiropoulou P., Giazitzoglou E., Karvouni E., Papamichail M. Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace 2007
   Google Scholar
• Luyten F. P. Mesenchymal stromal cells in osteoarthritis. Curr Opin Rheumatol 2004; 16: 599–603
   PubMed Web of Science ®Google Scholar
• Lazarus H. M., Haynesworth S. E., Gerson S. L., Rosenthal N. S., Caplan A. I. Ex vivo expansion and subsequent infusion of human bone marrow‐derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995; 16: 557–64
   PubMed Web of Science ®Google Scholar
• Lazarus H. M., Koc O. N., Devine S. M., Curtin P., Maziarz R. T., Holland H. K., et al. Cotransplantation of HLA‐identical sibling culture‐expanded mesenchymal stromal cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389–98
   PubMed Web of Science ®Google Scholar
• Bang O. Y., Lee J. S., Lee P. H., Lee G. Autologous mesenchymal stromal cell transplantation in stroke patients. Ann Neurol 2005; 57: 874–82
   PubMed Web of Science ®Google Scholar